AU1972097A - Process for the preparation of form 1 ranitidine hydrochloride - Google Patents

Process for the preparation of form 1 ranitidine hydrochloride

Info

Publication number
AU1972097A
AU1972097A AU19720/97A AU1972097A AU1972097A AU 1972097 A AU1972097 A AU 1972097A AU 19720/97 A AU19720/97 A AU 19720/97A AU 1972097 A AU1972097 A AU 1972097A AU 1972097 A AU1972097 A AU 1972097A
Authority
AU
Australia
Prior art keywords
preparation
ranitidine hydrochloride
ranitidine
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19720/97A
Inventor
Roger L. Briggs
Wen J. Cheng
Lee V. Mccoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of AU1972097A publication Critical patent/AU1972097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
AU19720/97A 1996-03-25 1997-02-25 Process for the preparation of form 1 ranitidine hydrochloride Abandoned AU1972097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62082296A 1996-03-25 1996-03-25
US08620822 1996-03-25
PCT/US1997/002867 WO1997035853A1 (en) 1996-03-25 1997-02-25 Process for the preparation of form 1 ranitidine hydrochloride

Publications (1)

Publication Number Publication Date
AU1972097A true AU1972097A (en) 1997-10-17

Family

ID=24487544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19720/97A Abandoned AU1972097A (en) 1996-03-25 1997-02-25 Process for the preparation of form 1 ranitidine hydrochloride

Country Status (3)

Country Link
AU (1) AU1972097A (en)
TW (1) TW350842B (en)
WO (1) WO1997035853A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999065890A1 (en) * 1998-06-17 1999-12-23 Russinsky Limited Ranitidine adduct
CN106397374A (en) * 2015-05-26 2017-02-15 烟台市华文欣欣医药科技有限公司 Method for preparing ranitidine hydrochloride compound as drug for treating stomach diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
DE69504156T2 (en) * 1994-06-24 1998-12-24 Ranbaxy Lab Ltd Process for the production of ranitidine hydrochloride in crystal form 1

Also Published As

Publication number Publication date
WO1997035853A1 (en) 1997-10-02
TW350842B (en) 1999-01-21

Similar Documents

Publication Publication Date Title
AU4525396A (en) Process for the preparation of perfluorocarbons
IL129759A0 (en) Process for the preparation of benzyl-ethers
AU2734895A (en) Process for the preparation of 3-aryluracils
AU2762395A (en) Process for the preparation of azanoradamantane benzamides
AU8758298A (en) Process for the preparation of 2'-fluoro-5-methyl-beta -l-arabinofuranosyluridine
AU2173597A (en) Process for the preparation of tenidap
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
IL128195A0 (en) Process for the preparation of substituted valinamide derivatives
AU4468997A (en) Process for the preparation of fluoxetine
AU3783097A (en) Process for the preparation of hexanitrohexaazaisowurtzitanes
GR3035436T3 (en) Process for the preparation of 2-H-heptafluoropropane
AU2074997A (en) Process for the preparation of tetraethyl methylenebisphosphonate
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
EP0690053A3 (en) Process for the preparation of 2,5 Dihydrofurans
PH31401A (en) Process for the manufacture of form 1 ranitidine hydrochloride.
AU1972097A (en) Process for the preparation of form 1 ranitidine hydrochloride
ZA953682B (en) Process for the manufacture of Form 1 ranitidine hydrochloride
AU4208397A (en) Process for the preparation of nizatidine
AU1207497A (en) Process for the preparation of para-fluorophenol
IL118731A0 (en) Process for the preparation of 2,2-dialkyl-arylidene-cycloalkanones
EP0831156A4 (en) Process for the preparation of 3-alkoxymethylcephems
AU6764796A (en) Process for the preparation of 3,3,5-trichloroglutarimide
AU695181B2 (en) Process for the manufacture of form 1 ranitidine hydrochloride
AU5188198A (en) Process for the preparation of tetrahydro-5-oxo-pyrrolizine derivatives
HUP9600316A3 (en) Process for the preparation of n-(ortho-alkyl-phenyl)-imides